Drugs in general practice : report on a WHO meeting, Schlangenbad, 19-22 October 1982.
Material type:
TextSeries: EURO reports and studies ; 91Publication details: Copenhagen : WHO Regional Office for Europe, 1985. Description: 45 pISBN: 9289012579Subject(s): Prescriptions, Drug | Family practice | Pharmacology, Toxicology and Clinical TechnologyNLM classification: QV 748Online resources: Click here to access online Abstract: A critical assessment of factors influencing the drug prescribing practices of general practitioners. Because of the problems created by overutilization of medical resources, particular attention is given to factors that can leadto the overprescribing of drugs. Topics range from an explanation of why doctors may allow their practices to be dominated by drug prescribing, through the impact of information supplied verbally and in print by the pharmaceutical industry, to the reasons for poor communication between drug regulatory agencies and physicians. A section on the use of prescription audits is also included.
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Books
|
WHO HQ READING-RM | EURO SERIAL (Browse shelf(Opens below)) | 1 | Available | 00013707 | |
|
Books
|
WHO HQ BORROWABLE-COLL-STACKS | QV 748 85EU (Browse shelf(Opens below)) | 2 | Withdrawn | 00013706 | |
|
Books
|
WHO HQ ONLINE-IRIS | QV 748 85EU (Browse shelf(Opens below)) | 3 | Available | O42097 |
Korean edition with: The Use of essential drugs. WHO technical report series no. 867.
A critical assessment of factors influencing the drug prescribing practices of general practitioners. Because of the problems created by overutilization of medical resources, particular attention is given to factors that can leadto the overprescribing of drugs. Topics range from an explanation of why doctors may allow their practices to be dominated by drug prescribing, through the impact of information supplied verbally and in print by the pharmaceutical industry, to the reasons for poor communication between drug regulatory agencies and physicians. A section on the use of prescription audits is also included.
DC.EURO
eng with summaries in fre ger rus.
kor.
WHO monograph
ICP/PHB 009(11)
4
There are no comments on this title.